1-2 of 2
Françoise Picard
Close
Sort by
Journal Articles

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, Sophie Grabar, Véronique Della-Valle, Françoise Picard, Franck Viguié, Bruno Quesnel, Odile Beyne-Rauzy, Eric Solary, Norbert Vey, Mathilde Hunault-Berger, Pierre Fenaux, Véronique Mansat-De Mas, Eric Delabesse, Philippe Guardiola, Catherine Lacombe, William Vainchenker, Claude Preudhomme, François Dreyfus, Olivier A. Bernard, Daniel Birnbaum, Michaëla Fontenay, on behalf of the Groupe Francophone des Myélodysplasies
Journal: Blood
Blood (2009) 114 (15): 3285–3291.
https://doi.org/10.1182/blood-2009-04-215814
Published: 2009
Includes: Supplemental data
Journal Articles

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

Clinical Trials & Observations
Sophie Park, Sophie Grabar, Charikleia Kelaidi, Odile Beyne-Rauzy, Françoise Picard, Valérie Bardet, Valérie Coiteux, Geneviève Leroux, Pascale Lepelley, Marie-Thérèse Daniel, Stéphane Cheze, Béatrice Mahé, Augustin Ferrant, Christophe Ravoet, Martine Escoffre-Barbe, Lionel Adès, Norbert Vey, Lina Aljassem, Aspasia Stamatoullas, Lionel Mannone, Hervé Dombret, Keith Bourgeois, Peter Greenberg, Pierre Fenaux, François Dreyfus
Journal: Blood
Blood (2008) 111 (2): 574–582.
https://doi.org/10.1182/blood-2007-06-096370
Published: 2008
Includes: Supplemental data